- Unstable therapy for components of the metabolic syndrome (ie. recent starting or stopping of insulin sensitizing agent, lipid lowering agent, and/or antioxidant therapy) . Recent starting or stopping (for more than 7 days) the use of a thiazolidinedione (pioglitazone or rosiglitazone) 90 days before the entry biopsy or anytime thereafter